This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA finds no cancer link for Vytorin but cannot rule out risk
The FDA said data from SEAS and other studies show no evidence Vytorin increases cancer risk or cancer deaths, though long term Zetia data remain insufficient to completely rule out a risk. Regulators urge continued evaluation of benefits versus risks and advise consulting physicians.
MENTIONED IN THIS ARTICLE
Trenton
N.J
Merck & Co
Food and Drug Administration
FDA
Merck
Ron Rogers
Zocor
SEAS
Schering-Plough Corp
Vytorin
Zetia. Com